Pharma giant partners with Durham firm to target sickle cell disease
IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...
The Pharma Letter20h
Novo Nordisk teams up with IMMvention Therapeutix on SCD
USA-based biotech IMMvention Therapeutix yesterday revealed it has entered into a strategic collaboration and license ...
PipelineReview.com14h
Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...
ncbiotech.org4h
Azzur serves NC biosciences with “Cleanrooms on Demand”
Azzur Cleanrooms on Demand (COD) has entered this acronym-laden environment to provide cleanroom and laboratory spaces for so-called GxP manufacturing support. Opened in May 2023, it’s a 75,000-square ...